Viewing StudyNCT02759835



Ignite Creation Date: 2024-05-06 @ 8:30 AM
Last Modification Date: 2024-10-26 @ 12:01 PM
Study NCT ID: NCT02759835
Status: COMPLETED
Last Update Posted: 2024-06-07
First Post: 2016-04-06

Brief Title: Local Ablative Therapy for Treatment of Oligoprogressive EGFR-Mutated Non-Small Cell Lung Cancer After Treatment With Osimertinib
Sponsor: National Cancer Institute NCI
Organization: National Institutes of Health Clinical Center CC

Conditions & Keywords Data

Conditions:
Name
Lung Neoplasms
Lung Adenocarcinoma
Keywords:
Name View
Acquired Resistance View
EGFR Tyrosine Kinase Inhibitors View
T790M Mutation View
Local Ablative Therapies View
Oligoprogressive Disease View